Reversible skin and hair depigmentation during chemotherapy with dasatinib for chronic myeloid leukemia.
J Dermatol
; 43(1): 106-7, 2016 Jan.
Article
in En
| MEDLINE
| ID: mdl-26434556
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pigmentation
/
Leukemia, Myeloid, Accelerated Phase
/
Dasatinib
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
J Dermatol
Year:
2016
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom